Lanxess AG buy DirectorDealer
Start price
22.07.16
/
50%
€41.77
Target price
23.01.17
€45.95
Performance (%)
58.43%
End price
23.01.17
€66.17
Summary
This prediction ended on 23.01.17 with a price of €66.17. With a performance of 58.43% the BUY prediction by DirectorDealer was a big success. DirectorDealer has 50% into this predictionLanxess is a German specialty chemicals company that produces a wide range of chemical products and additives for industries such as automotive, construction, and electronics. With operations in over 33 countries, its product portfolio includes high-performance plastics, synthetic rubber, performance chemicals, and water treatment solutions. The company is listed on the Frankfurt Stock Exchange and has a secondary listing on the OTC markets in the US under the symbol LNXSF.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Lanxess AG | 0.286% | 0.286% | -22.453% | -60.367% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by DirectorDealer for this prediction
In the thread Lanxess AG diskutieren
Director Dealing: Kauf
Director Dealing / Insider Kauf von Fink, Hubert (Geschäftsführendes Organ)
- Handelstag: 18.01.16
- Volumen: 198979 €
- Meldender: Fink, Hubert
Wir werten alle Insider Käufe aus. Dabei werden die größten Insiderkäufe und Verkäufe automatisch als Einschätzung angelegt. Mehr Informationen findest du im Profil von DirectorDealer.
Director's Dealing / Insider Kauf von Stomberg, Dr. Rolf (Aufsichtsrat)
- Handelstag: 11.01.17
- Volumen: 53511 €
- Meldender: Stomberg, Dr. Rolf
(Laufzeit überschritten)